News
Preclinical data supports the advancement of oral Ketamir-2 as a safe, next-generation alternative to ketamine, with ongoing momentum in Phase I clinical trial enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback